In a move that reshapes access to COVID-19 vaccines, the FDA now requires clinical trials to prove benefits for low-risk groups, while limiting vaccine availability to adults over 65 and those with risk factors like asthma and diabetes.
Corporate media and billionaire owners shape much of the news landscape. Meanwhile, disinformation and dwindling local coverage leave communities in the dark.
Planet Detroit is different. Readers, not shareholders, power us—delivering fact-based, independent reporting on climate, health, and the environment. No paywalls. No outside influence. Just journalism that puts you first.
If you value our work, please consider supporting our nonprofit newsroom. Every contribution, big or small, makes a difference—and takes less than a minute. Thank you.
In a move that reshapes access to COVID-19 vaccines, the FDA now requires clinical trials to prove benefits for low-risk groups, while limiting vaccine availability to adults over 65 and those with risk factors like asthma and diabetes.